Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
The new formulation features what Abbott calls a “triple care system,” anchored by a blend of nutrients aimed at supporting blood sugar control and metabolic health
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The integration of AHG’s specialized cold chain transportation and third-party logistics (3PL) solutions will significantly strengthen UPS Healthcare’s service offerings
Kulzer has consolidated the production of its core product, artificial teeth, at its facility in Germany
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Subscribe To Our Newsletter & Stay Updated
